Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Iveco Bus launches comprehensive New Daily minibus range to meet Euro VI

Stand 5F10, Hall 5, CV Show 2016 – 26-28 April 2016The CV Show marks the UK launch of the New Daily minibus range powered by Euro VI engines – delivering more power, lower fuel consumption, best-in-class total cost of ownership (TCO) and increased comfort for both the driver and passengers. The updates make the New Daily minibus range the perfect business partner. Basildon, April 26, 2016 Iveco Bus is expanding its presence in the UK market and using its extensive experience in the passenger transport sector to introduce a full range of New Daily minibus models at Euro VI. The models

Pihlajalinna Plc:Pihlajalinna Oyj publishes January-March 2016 Interim Report on Tuesday, May 10, 2016 at 08.00 a.m (EEST).

Pihlajalinna Oyj Stock Exchange release, April 26, 2016 at 10.30 a.m. (EEST) Pihlajalinna Oyj publishes January-March 2016 Interim Report on Tuesday, May 10, 2016 at 08.00 a.m (EEST). Interim Report Pihlajalinna Oyj will publish the Interim Report for the period January 1-March 31, 2016 on Tuesday, May 10, 2016 at 08:00 a.m. (EEST). The report will be available on the company website investors.pihlajalinna-konserni.fi . Press and analyst meeting A meeting for analysts and the press conducted in Finnish, will be held on

Muscle & Fitness recommend Adidas Techfit Climachill long sleeve with Polygiene

We are super excited about working with Adidas in the Techfit Climachill line providing a full circle of functionality.Muscle&Fitness - Spring FItness Guide Threads The wear and feel of the material, the compression, the wicking and odor control with Polygiene Odor Control Technology work in synergy for maximal comfort, allowing you to fully focus on the activity you are going for. Muscle&Fitness  recommends the Adidas Techfit Climachill long sleeve with Polygiene Odor Control Technology  in their Spring

Promising designer wins Kappahl Sustainable Design Contest

A unanimous jury has named Lovisa Malmberg Gomis winner of the KappAhl Sustainable Design Contest. The winning entry was all about creating intelligent clothes that are both sustainable and usable.     “The level of creativity in the competition entries surpassed our expectations. We see real potential to develop the winning entry here at KappAhl – in more ways than one,” explains Head of Design Paul Laing.The winning entry was based on the concept of designing so-called “intelligent clothing”. That’s to say versatile clothes with more than one possible area of use, meaning they last

Concordia Maritime signs new contract for P-MAX tanker

Concordia Maritime has signed a new consecutive voyage contract for the P-MAX tanker Stena Polaris. The contract, which comes into effect in May 2016, is for one year. The contractual partner is one of the world’s largest oil and gas companies.“This is a new niche trade that we have identified together with our customer. The new contract clearly demonstrates that we have found an arrangement that creates value for all parties. The customer has a specific transport need for which the large load capacity of the P-MAX tankers will be well suited. For our part, the contract is fully in line

Scandic strengthens customer dialog through new digital platform

Scandic Hotels, the largest hotel company in the Nordics, is continuing to strengthen its customer dialog and market-leading e-commerce by launching a new digital platform. The platform will improve the customer experience and service level as well as further increase the site’s conversion rate. The first step is today’s launch of a new commercial website in seven languages.To optimize meeting customer requirements and the growing demand for dialog and service in digital channels going forward, Scandic has invested in a new digital commercial platform with a focus on the customer experience,

Caverion, SKB and Vattenfall extend the framework agreement for two nuclear power plants in Sweden

Caverion Corporation    Investor News    April 26, 2016 at 10.00 a.m. EESTCaverion, SKB and Vattenfall extend the framework agreement for two nuclear power plants in Sweden Caverion, SKB, Swedish Nuclear Fuel and Waste Management Company, and Vattenfall, one of Europe's largest generators of electricity, extend the framework agreement for the Ringhals and Forsmark nuclear power plants. The agreement for the years 2016-2018 covers the service areas of Design & Engineering,  Project Execution, Technical Maintenance and Managed Services. The value of the contract is not disclosed. “We

Photocure ASA: New analysis shows Hexvix®/Cysview® significantly prolongs time to progression of bladder cancer

Photocure ASA Oslo, Norway, 26[th] April 2016: Photocure ASA (OSE: PHO), is pleased to announce publication of a new analysis demonstrating that Blue Light Cystoscopy (BLC) with Hexvix/Cysview significantly prolonged time to disease progression and showed a trend in the reduction of the rate of progression in patients with non-muscle invasive bladder cancer (NMIBC).  The data was published online in the April issue of the peer reviewed journal, Bladder Cancer http://content.iospress.com/articles/bladder-cancer/blc160048. The new analysis of a long term follow-up study classified patients

SRV has been chosen to further develop the historical, valued at about EUR 300 million, new central hospital project in Central Finland

SRV GROUP PLC     STOCK EXCHANGE RELEASE     26.04.2016, KLO 10.00SRV has been chosen to further develop the historical, valued at about EUR 300 million, new central hospital project in Central FinlandSRV has been chosen to be a futher developer for Central Finlands Central Hospital. SRV can also be chosen to be a management contractor for a EUR 300 million new hospital project, if the final target price set by Central Finland Health Care District is achieved. In that case, the project will be largest in company´s history, which do not include the company´s own equity.On 26 April, the

SimCorp A/S - Business transacted at the extraordinary general meeting

Today, 26 April 2016, SimCorp A/S held its extraordinary general meeting, at which the following was adopted: · New shares issued in accordance with the Board’s existing authority to increase the share capital shall in the future not be issued to bearer but in the name of the holder.  · Authorization of the Board of Directors, in accordance with sections 182-183 of the Danish Companies Act, to approve distribution of extraordinary dividends to the extent that the Company’s and the group’s financial situation warrants it. The extraordinary dividends must be reasonable in relation

TORM plc: Notice of squeeze-out of remaining shares in TORM A/S pursuant to Sections 70 and 72 of the Danish Companies Act

This announcement does not constitute an offering circular or prospectus in connection with an offering of securities of TORM plc. Investors must neither accept any offer for, nor acquire or subscribe for, any securities to which this document refers, unless they do so on the basis of the information contained in the prospectus made available by TORM plc in those jurisdictions where an offer may be made (if an offer is made). This announcement does not constitute an offer to sell or the solicitation of an offer to buy or subscribe for any securities and cannot be relied on for any

Meg Rosoff to Sweden

Author Meg Rosoff is coming to Sweden to receive the 2016 Astrid Lindgren Memorial Award (ALMA). The Award Week begins May 23 and ends with the award ceremony at the Stockholm Concert Hall on May 30.  “That´s amazing, I have to sit down, I can´t believe that” was Rosoff’s reaction when Jury Chairman Boel Westin informed the American writer living in London that she is the laureate of the world’s largest award for children’s and young adult literature. The program for the award week includes meetings with press and media, meetings with children and young adults and a visit to Astrid

Interim report January-March 2016: Good growth in all regions

· Sales amounted to SEK 187 (162) million, corresponding to an increase of 15 percent in SEK. Sales growth was 16 percent in local currency. · Operating income before depreciation and amortization (EBITDA) amounted to SEK 62 (54) million, corresponding to a margin of 33 (33) percent. Operating income included one-time expenses of SEK 5 million related to the planned consolidation of the time-lapse business. Adjusted for this, the margin amounted to 36 percent. · Launch of a new range of aspiration needles for oocyte retrieval. · Net income amounted to SEK 39 (35) million, which

NeuroVive starts preclinical TBI program in collaboration with PENN

NeuroVive Pharmaceutical AB (publ), the pioneers in mitochondrial medicine, announces the start of the first study in the preclinical program in traumatic brain injury (TBI) which is being done in collaboration with the University of Pennsylvania (PENN).The TBI preclinical research program includes 3 different studies evaluating the protective effect of NeuroSTAT® in a TBI experimental model. TBI is an important unsolved problem in the medical field: nerve cell protection following moderate to severe brain trauma. There currently exist no approved treatments for this medical problem

XVIVO Perfusion Interim report January – March 2016

17% GROWTH* EXCL. DURABLE GOODS AND 22% EBITDA MARGIN EXCL. ONE-TIME COSTSFIRST QUARTER 2016 (JAN – MAR)  • Net sales of non-Durable goods** in the quarter amounted to SEK 29.1 (25.1) million, corresponding to an increase of 16 percent in SEK. Sales of non-Durable goods increased by 17 percent in local currency. Net sales in the quarter amounted to SEK 33.5 (31.8) million, corresponding to an increase of 5 percent.• Operating income before depreciation and amortization (EBITDA) excluding one-time expenses amounted to SEK 7.3 (4.5) million, corresponding to an EBITDA margin of 22

SKF divests Kaydon velocity control business

Gothenburg, 26 April 2016: SKF has signed an agreement, subject to regulatory approvals, to divest its Kaydon velocity control business to Stabilus, a global supplier to the automotive and industrial markets. Stabilus develops and produces electromechanical drives, as well as gas springs and hydraulic dampers. The company has its operational headquarters in Koblenz, Germany and is listed on the SDAX index of the Frankfurt Stock Exchange. The total consideration of the transaction is USD 339 million, on a cash- and debt-free basis, and it is expected to close during the summer of 2016.

Constitutive meeting of Biohit Oyj’s Board of Directors

Biohit Oyj Stock Exchange Release April 26, 2016 at 9:30 AM local time (EEST) Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the Chairman of the Board of Directors. Additional information: CEO Semi Korpela, Biohit Oyjtel. +358 9 773 861investor.relations@biohit.fiwww.biohithealthcare.com   Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered

Sectra’s financial reporting calendar for 2016/2017

Linköping, Sweden, April 26, 2016 – The Board of Directors of Sectra AB (STO: SECT B) has decided on the dates for the company’s financial reporting for the coming fiscal year.The following dates are planned for Sectra’s financial reporting: · May 31, 2016: Year-end report 2015/2016 · September 5, 2016: Three-month report · September 6, 2016: Annual General Meeting in Linköping at 4:00 p.m. · December 7, 2016: Six-month report · March 7, 2017: Nine-month report · May 30, 2017: Year-end report 2016/2017 Presentation of the year-end report with detailed information on

Interim report Q1/2016: Growth projects and cost efficiency measures deliver improved earnings

UPM-Kymmene Corporation      Stock Exchange Release         26 April 2016 at 9:25 EET Interim report Q1/2016: Growth projects and cost efficiency measures deliver improved earnings Q1 2016 highlights · Comparable EBIT increased by 34% to EUR 281 million (210 million).· Growth projects contributed to UPM's earnings, with increasing deliveries in pulp, biofuels, label papers, fine papers in Asia and self-adhesive label materials.· Variable and fixed costs decreased significantly, showing the full impact of last year's cost efficiency measures.· Operating cash flow was strong at

Type of container cargo no longer affects price in market defined by oversupply, discloses Xeneta

26 April 2016, Oslo: Xeneta can reveal that containership carriers are no longer pricing cargo according to type. Simply filling their vessels is now the number one priority. The Oslo-based benchmarking and market intelligence platform for containerized ocean freight argues that oversupply, better supply chain management and downwardly spiralling fuel costs have made the market so competitive over the last 18 months that ‘what’s in the box’ no longer plays a part in negotiations. Data gathered by the firm illustrates that the market average price for transporting a 40-foot container from

Rental growth and value increases produce strong earnings

After-tax profit for the quarter amounted to SEK 1,665m (705). Rental income increased to SEK 519m (502) as a result of completed project properties generating revenue. In an identical portfolio, income rose by 4 per cent. Investments, rising market rents and lower yield requirements on the market contributed to strong value growth in the property portfolio.Increased rental income and lower interest expenses led to a 16 per cent increase in profit from property management. Persistently declining yield requirements on the property market and value-adding projects paved the way for continued

AstraZeneca PLC Announces Bevespi Aerosphere(TM) Approved by the US FDA for Patients With COPD

Demonstrated superior improvement in lung function versus mono-components and placebo Only long-acting dual bronchodilator delivered through a pressurised metered-dose inhaler (pMDI) and first product to use AstraZeneca's patented Co-Suspension(TM) TechnologyAstraZeneca  has announced that the US Food and Drug Administration has approved Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) inhalation aerosol indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including

Sulkava and Rääkkylä choose Attendo for combination contracts

The municipality of Sulkava in Finland has chosen Attendo as the new provider of all care and healthcare services to its citizens. In a separate decision, Rääkkylä municipality has chosen to extend its current combination contract with Attendo for another four years.Sulkava municipal board decided at its board meeting on April 25 to award Attendo the combination contract for providing the municipality’s social and health care services. The decision will be effective as soon as the appeal period has passed and the contract has been signed. “We are delighted about Sulkava’s vote of

There are no items matching the current filter
There are no more items matching the current filter
Back to top